All had ECOG performance status of 0 (28.1%) or 1 (71.9%). Nearly two-thirds (62.5%) had endometrioid adenocarcinoma, and 25% had received at least two prior therapies. All women had disease ...

Trop-2 is a glycoprotein involved in cellular signal transduction and is differentially overexpressed relative to normal tissue in a variety of human adenocarcinomas, including endometrioid ...